1
|
Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
|
J Clin Psychopharmacol
|
2007
|
1.41
|
2
|
The validity of an Internet-based Self-assessment Program for Depression.
|
AMIA Annu Symp Proc
|
2003
|
1.13
|
3
|
Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.
|
Pharmacogenet Genomics
|
2010
|
0.84
|
4
|
Intercorrelations between the Personal and Social Performance Scale, cognitive function, and activities of daily living.
|
J Nerv Ment Dis
|
2011
|
0.80
|
5
|
Myasthenia gravis and respiratory failure in a patient with schizophrenia.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2010
|
0.80
|
6
|
Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
|
Neuromolecular Med
|
2011
|
0.79
|
7
|
Persistent psychosis after ingestion of a single tablet of '2C-B'.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2010
|
0.78
|
8
|
Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
|
World J Biol Psychiatry
|
2011
|
0.75
|
9
|
Comment to Dr. Yatham regarding tamoxifen listed as a third-line recommendation for the pharmacological treatment of acute mania.
|
Bipolar Disord
|
2009
|
0.75
|
10
|
Genetic variants of microsomal triglyceride transfer protein (MTTP) are associated with metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.
|
J Clin Psychopharmacol
|
2013
|
0.75
|
11
|
Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease.
|
Gen Hosp Psychiatry
|
2011
|
0.75
|